These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21223531)

  • 1. The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.
    Dubberke ER; Haslam DB; Lanzas C; Bobo LD; Burnham CA; Gröhn YT; Tarr PI
    Zoonoses Public Health; 2011 Feb; 58(1):4-20. PubMed ID: 21223531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile: a reemerging pathogen.
    Calfee DP
    Geriatrics; 2008 Sep; 63(9):10-21. PubMed ID: 18763846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes].
    Notermans DW; van der Kooi TI; Goorhuis A; Debast SB; van Benthem BH; Kuijper EJ
    Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1937-40. PubMed ID: 18808085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move.
    Valiente E; Cairns MD; Wren BW
    Clin Microbiol Infect; 2014 May; 20(5):396-404. PubMed ID: 24621128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection: new developments in epidemiology and pathogenesis.
    Rupnik M; Wilcox MH; Gerding DN
    Nat Rev Microbiol; 2009 Jul; 7(7):526-36. PubMed ID: 19528959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile in Food and Animals: A Comprehensive Review.
    Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
    Adv Exp Med Biol; 2016; 932():65-92. PubMed ID: 27350639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile: an emerging pathogen in children.
    Khalaf N; Crews JD; DuPont HL; Koo HL
    Discov Med; 2012 Aug; 14(75):105-13. PubMed ID: 22935207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital signs: preventing Clostridium difficile infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(9):157-62. PubMed ID: 22398844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human C. difficile infections are increasing in incidence and severity.
    Zoonoses Public Health; 2011 Feb; 58(1):1-3. PubMed ID: 21083827
    [No Abstract]   [Full Text] [Related]  

  • 10. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin.
    Janvilisri T; Scaria J; Thompson AD; Nicholson A; Limbago BM; Arroyo LG; Songer JG; Gröhn YT; Chang YF
    J Bacteriol; 2009 Jun; 191(12):3881-91. PubMed ID: 19376880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientists seek strategies to prevent Clostridium difficile infections.
    Kuehn BM
    JAMA; 2011 Nov; 306(17):1849-50. PubMed ID: 22045758
    [No Abstract]   [Full Text] [Related]  

  • 12. Early qualitative risk assessment of the emerging zoonotic potential of animal diseases.
    Palmer S; Brown D; Morgan D
    BMJ; 2005 Nov; 331(7527):1256-60. PubMed ID: 16308389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of nosocomial Clostridium difficile infection.
    Samore MH
    Compr Ther; 1993; 19(4):151-6. PubMed ID: 8261769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in Clostridium difficile-associated disease.
    Monaghan T; Boswell T; Mahida YR
    Gut; 2008 Jun; 57(6):850-60. PubMed ID: 18252748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clostridium difficile-associated infections. How dangerous are the new strains?].
    Kola A
    Internist (Berl); 2010 Feb; 51(2):154-60. PubMed ID: 19997894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of 'hypervirulence' in Clostridium difficile.
    Cartman ST; Heap JT; Kuehne SA; Cockayne A; Minton NP
    Int J Med Microbiol; 2010 Aug; 300(6):387-95. PubMed ID: 20547099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simulation-based assessment of strategies to control Clostridium difficile transmission and infection.
    Rubin MA; Jones M; Leecaster M; Khader K; Ray W; Huttner A; Huttner B; Toth D; Sablay T; Borotkanics RJ; Gerding DN; Samore MH
    PLoS One; 2013; 8(11):e80671. PubMed ID: 24278304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile: a new zoonotic agent?
    Indra A; Lassnig H; Baliko N; Much P; Fiedler A; Huhulescu S; Allerberger F
    Wien Klin Wochenschr; 2009; 121(3-4):91-5. PubMed ID: 19280132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection in humans and piglets: a 'One Health' opportunity.
    Squire MM; Riley TV
    Curr Top Microbiol Immunol; 2013; 365():299-314. PubMed ID: 22695920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervirulent Clostridium difficile strains in hospitalized patients, Canada.
    Mulvey MR; Boyd DA; Gravel D; Hutchinson J; Kelly S; McGeer A; Moore D; Simor A; Suh KN; Taylor G; Weese JS; Miller M;
    Emerg Infect Dis; 2010 Apr; 16(4):678-81. PubMed ID: 20350386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.